Screener
Merck & Co. MRK Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Merck & Co. in its filing.
Tagged under the XBRL concept us-gaap:DebtCurrent.
The source filing: Merck & Co.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:11 PM EDT
- Fiscal quarter
- Q3 FY2028
- Calendar quarter
- Q3 2028
- Accession
- 0000310158-26-000212
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| $129,802 | $136,866 | |
| Liabilities and Equity | ||
| Current Liabilities | ||
| Loans payable and current portion of long-term debt | $2,825 | $2,589 |
| Trade accounts payable | 3,827 | 4,404 |
| Accrued and other current liabilities | 14,725 | 14,468 |
| Income taxes payable | 4,224 | 4,726 |
| Dividends payable | 2,130 | 2,140 |
Item 1. Financial Statements
FAQ
- What is Merck & Co.'s current debt?
- Merck & Co. (MRK) reported current debt of $2.83B in Q2 2026.
- How has Merck & Co.'s current debt changed year-over-year?
- Merck & Co.'s current debt increased by 97.0% year-over-year, from $1.43B to $2.83B.
- What is the long-term trend for Merck & Co.'s current debt?
- Over 5 years (2020 to 2025), Merck & Co.'s current debt has grown at a 0.0% compound annual growth rate (CAGR), from $2.3B to $2.3B.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.
Ask your AI about Merck & Co.'s current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude